Evaluation of plasma 3,4-dihydroxyphenylacetic acid (DOPAC) and plasma 3,4-dihydroxyphenylalanine (DOPA) as tumor markers in children with neuroblastoma

Author： Eldrup E.   Clausen N.   Scherling B.   Schmiegelow K.  

Publisher： Informa Healthcare

ISSN： 0036-5513

Source： Scandinavian Journal of Clinical and Laboratory Investigation, Vol.61, Iss.6, 2001-09, pp. : 479-490

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of Fluorescent Plasma Markers for in vivo Microscopy of the Microcirculation

By  

Journal of Vascular Research, Vol. 49, Iss. 2, 2012-01 ,pp. : 132-143

Karger

Access to resources Recommend Favorite

Evaluation of a Device for Negative Selection of CD34+ Cells Alone or in Combination with Breast Cancer Tumor Cell Purging

By  

Transfusion Medicine and Hemotherapy, Vol. 28, Iss. 2, 2001-04 ,pp. : 67-72

Karger

Access to resources Recommend Favorite

Genomic markers for neuroblastoma risk estimation: superseding tumor stage, age and MYCN?

By Oberthuer André  

Biomarkers in Medicine, Vol. 7, Iss. 6, 2013-12 ,pp. : 905-908

Future Medicine

Access to resources Recommend Favorite

EVALUATION OF DAZ MICRODELETIONS IN 34 INFERTILE MEN

By Abdelmoula N.   Sallemi A.   Chakroun N.   Keskes L.   Amouri A.   Rebai T.  

Archives of Andrology, Vol. 52, Iss. 3, 2006-07 ,pp. : 175-178

Informa Healthcare

Access to resources Recommend Favorite

Plasma homocysteine and markers of bone metabolism in psychogeriatric patients

By Nilsson K.   Gustafson L.   Isaksson A.   Hultberg B.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 65, Iss. 8, 2005-12 ,pp. : 671-680

Informa Healthcare

Access to resources Recommend Favorite